| Absorption |
| Blood-Brain Barrier | BBB+ | 0.6663 |
| Human Intestinal Absorption | HIA+ | 0.9946 |
| Caco-2 Permeability | Caco2+ | 0.8416 |
| P-glycoprotein Substrate | Substrate | 0.6618 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8918 |
| Non-inhibitor | 0.9235 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8387 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8347 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8220 |
| CYP450 2D6 Substrate | Substrate | 0.8886 |
| CYP450 3A4 Substrate | Non-substrate | 0.6800 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7551 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8989 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.5536 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8491 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7728 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8234 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9386 |
| Non-inhibitor | 0.6063 |
| AMES Toxicity | Non AMES toxic | 0.9139 |
| Carcinogens | Non-carcinogens | 0.9261 |
| Fish Toxicity | High FHMT | 0.8589 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8981 |
| Honey Bee Toxicity | High HBT | 0.5246 |
| Biodegradation | Not ready biodegradable | 0.9905 |
| Acute Oral Toxicity | II | 0.6456 |
| Carcinogenicity (Three-class) | Non-required | 0.6018 |